Dr. Sapna Syngal, MD
Claim this profileDana Farber Cancer Center, Harvard University
Studies Colorectal Cancer
Studies Pancreatic Cancer Testing
4 reported clinical trials
8 drugs studied
Area of expertise
1Colorectal Cancer
MSH2 positive
CTRC positive
PRSS1 positive
2Pancreatic Cancer Testing
APC positive
ATM positive
BRCA1 positive
Affiliated Hospitals
Clinical Trials Sapna Syngal, MD is currently running
Surveillance and Prevention
for Cancer Risk
This research study is creating a way to collect and store specimens and information from participants who may be at an increased risk of developing cancer, or has been diagnosed with an early phase of a cancer or a family member who has a family member with a precursor condition for cancer. * The objective of this study is to identify exposures as well as clinical, molecular, and pathological changes that can be used to predict early development of cancer, malignant transformation, and risks of progression to symptomatic cancer that can ultimately be fatal. * The ultimate goal is to identify novel markers of early detection and risk stratification to drive potential therapeutic approaches to intercept progression to cancer.
Recruiting1 award N/A10 criteria
Stool-Based Markers
for Early Detection of Colon Cancer
Colon cancer is the second most common cancer in men and women. It is a disease that can be prevented if it is found early. Colonoscopy is still the best screening tool for colon cancer and the polyps that turn into colon cancer. However, due to a variety of factors, including affordability, time, and age, not all patients are able to be screened. Researchers are working on other options for early detection that are as accurate as colonoscopy. The purpose of this study if to determine if stool or blood can be used to detect colon cancers as early or earlier than colonoscopy. The researchers plan to use these samples to learn about specific proteins (also known as biomarkers) that may indicate colon polyps, colon cancer or an increased risk of developing colon cancer. In order to learn more about preventing and detecting colon and rectal cancer, we are collecting samples from subjects with cancer, adenomas, and colonoscopies who may be at risk for polyps.
Recruiting1 award N/A10 criteria
More about Sapna Syngal, MD
Clinical Trial Related2 years of experience running clinical trials · Led 4 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Sapna Syngal, MD has experience with
- Color Genomics Genetic Education
- Doxy.me Genetic Education +/- Color Genomics Genetic Education
- CA19-9
- Human Synthetic Secretin
- MRI
- Secretin
Breakdown of trials Sapna Syngal, MD has run
Colorectal Cancer
Pancreatic Cancer Testing
Pancreatic Cancer
Lynch Syndrome
Peutz-Jeghers Syndrome
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Sapna Syngal, MD specialize in?
Sapna Syngal, MD focuses on Colorectal Cancer and Pancreatic Cancer Testing. In particular, much of their work with Colorectal Cancer has involved MSH2 positive patients, or patients who are CTRC positive.
Is Sapna Syngal, MD currently recruiting for clinical trials?
Yes, Sapna Syngal, MD is currently recruiting for 3 clinical trials in Boston Massachusetts. If you're interested in participating, you should apply.
Are there any treatments that Sapna Syngal, MD has studied deeply?
Yes, Sapna Syngal, MD has studied treatments such as Color Genomics genetic education, Doxy.me genetic education +/- Color Genomics genetic education, CA19-9.
What is the best way to schedule an appointment with Sapna Syngal, MD?
Apply for one of the trials that Sapna Syngal, MD is conducting.
What is the office address of Sapna Syngal, MD?
The office of Sapna Syngal, MD is located at: Dana Farber Cancer Center, Harvard University, Boston, Massachusetts 02215 United States. This is the address for their practice at the Dana Farber Cancer Center, Harvard University.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.